SCHEMBL1734528

SCHEMBL1734528

Ic1ccc2ncnc(N3CCCCC3)c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 2/20 0.53
HTT P42858 7/20 0.50
PDGFRB P09619 1/20 0.50
MAP4K4 O95819 1/20 0.49
JAK3 P52333 2/20 0.48
PTK2 Q05397 1/20 0.48
ALDH1A1 P00352 3/20 0.47
LMNA P02545 2/20 0.47
MAPK1 P28482 2/20 0.47
HIF1A Q16665 2/20 0.47
CLK4 Q9HAZ1 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
NPSR1 Q6W5P4 2/20 0.47
IP6K1 Q92551 1/20 0.47
TSHR P16473 2/20 0.46
PRNP P04156 1/20 0.46
MAPT P10636 1/20 0.46
ALOX15 P16050 1/20 0.46
PPARG P37231 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4178072 0.98 PRKDC (0.52) PRKDCHTTPDGFRBMAP4K4JAK3
SCHEMBL1585491 0.95 HTT (0.51) PRKDCHTTPDGFRBPTK2ALDH1A1
SCHEMBL6785138 0.85 HTT (0.70) HTTPDGFRBALDH1A1LMNAMAPK1
SCHEMBL3115181 0.81 HTT (0.74) PRKDCHTTPDGFRBMAP4K4JAK3
SCHEMBL14595394 0.79 CHRM4 (0.58) HTTPDGFRBALDH1A1LMNAMAPK1
SCHEMBL2725752 0.79 PDGFRB (0.48) HTTPDGFRBPTK2ALDH1A1LMNA
SCHEMBL2882279 0.78 PRKDC (0.47) PRKDCHTTMAP4K4JAK3ALDH1A1
SCHEMBL30821993 0.77 PTK2 (0.71) PRKDCHTTJAK3PTK2ALDH1A1
SCHEMBL6569122 0.77 PTK2 (0.71) PRKDCHTTJAK3PTK2ALDH1A1
SCHEMBL4356019 0.77 HTT (0.55) HTTMAP4K4ALDH1A1LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8318932-B2 Process for producing 4-aminoquinazoline compound UBE INDUSTRIES, LTD. (JP) 2012-11-27 US disclosed
EP-1481971-B1 PROCESS FOR PRODUCING 4-AMINOQUINAZOLINE COMPOUND UBE INDUSTRIES (JP) 2011-11-16 EP disclosed
WO-2011131610-A1 HEAT TRANSFER MEDIUM BASED ON SULPHUR AND USE OF THE HEAT TRANSFER MEDIUM SIEMENS AKTIENGESELLSCHAFT (DE) 2011-10-27 WO disclosed
US-20090171083-A1 PROCESS FOR PRODUCING 4-AMINOQUINAZOLINE COMPOUND UBE INDUSTRIES, LTD. (JP) 2009-07-02 US disclosed
US-20080177069-A1 PROCESS FOR PRODUCING 4-AMINOQUINAZOLINE COMPOUND UBE INDUSTRIES, LTD. (JP) 2008-07-24 US disclosed
US-20050130995-A1 Chlorinating quinazolin-4-one in solvent in presence of a base; then reacting with an amine compound UBE INDUSTRIES, LTD. (JP) 2005-06-16 US disclosed
EP-1481971-A1 PROCESS FOR PRODUCING 4-AMINOQUINAZOLINE COMPOUND Ube Industries, Ltd. (JP) 2004-12-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090171083-A1 PROCESS FOR PRODUCING 4-AMINOQUINAZOLINE COMPOUND HRH4, CYP3A4, HRH3 PRKDC 1033/4885HTT 1926/4885PDGFRB 804/4885
US-20080177069-A1 PROCESS FOR PRODUCING 4-AMINOQUINAZOLINE COMPOUND HRH4, CYP3A4, HRH3 PRKDC 1033/4885HTT 1926/4885PDGFRB 804/4885
US-20050130995-A1 Chlorinating quinazolin-4-one in solvent in presence of a base; then reacting with an amine compound HRH4, HRH3, H1-4 PRKDC 1394/4885HTT 2023/4885PDGFRB 1112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.